Alliance professionals with long tenure in companies, cross-functional expertise and extensive networks have undisputed value to their organizations, but this should not mean that skills and capabilities won't transfer to other companies seeking out top alliance talent.
If this panel is a trend, alliance management is becoming a more mobile career. Has changing companies been a career hesitation for alliance managers? How can knowledge transfer while respecting a former employer's information? Is there a perceived uncertainty about the opportunities for leadership advancement? How best should internal advancement opportunities be balanced with external ones?
These three long-time ASAP members will share their experiences and provide practical insights about moving from big pharmaceutical companies after many years to new alliance management leadership roles. Join the discussion about the opportunities and challenges:
Karen Denton, CA-AM
Head of Alliance Management
Karen recently joined Esperion and is building out their alliance capability as they prepare to launch a non-statin, oral lipid lowering portfolio globally in partnership with Daiichi Sankyo Europe GmbH.
Karen is a long-standing member of ASAP and has participated in many of the Global Alliance Summits and BioPharma Conferences. Previously Karen was responsible for Bayer's oncology alliances and lead Bayer's Alliance Center of Excellence.
Currently based in New Jersey Karen is originally from UK and has held positions in sales, sales management, global marketing and business development.
Karen has a BSc in biology and a MA in marketing.
Nancy Griffin, CA-AM
Vice President, Alliance Management
Nancy Griffin has recently joined Vertex Pharmaceuticals as the Head of Alliance Management to build the alliance capability and manage the increasing alliance portfolio.Prior to this role, Nancy was the Head of AM in Global BD&L at Novartis, responsible for alliance management functional expertise across Novartis, having previously managed the alliance function within the Novartis Oncology Business Unit.Nancy has 20 years of international experience in the pharmaceutical sector including business development and licensing, business intelligence and drug development consisting of clinical operations, regulatory and clinical trial management.Prior to joining Novartis in 2007, Nancy held a variety of progressive positions with Bayer Healthcare, Targon – a joint venture in oncology between Elan Pharmaceuticals and Cytogen Corporation, and with Novo Nordisk.Nancy has worked both in the US and Canada, and in positions of local, regional and global responsibility.
Nancy has an undergraduate degree in Nursing Science from the University of Toronto, an MBA from Quinnipiac University in Connecticut and most recently, an MPH from George Washington University.
Steve Twait, CSAP
Vice President, Alliance and Integration Management (AIM)
Steve has responsibility for AstraZeneca's alliance and integration management (AIM) strategy and execution capabilities. Steve's team leads the integration of all major acquisitions, the transitions for divestments, and management of key alliances for AZ.Steve joined AZ in January 2015, after spending 26 years at Eli Lilly and Company where he was a founding member of Lilly's Office of Alliance Management. Steve is a well published author in Pharmaceutical Executive, PLG's Business Development & Licensing Journal, and Strategic Alliance Magazine and is a board member and treasurer of the Association of Strategic Alliance Professionals.